WDB HOLDINGS (2475) FY2026 Q3 Earnings Report

Quick View

Executive Summary

FY2026 Q3 cumulative results show revenue of 38.12 billion yen (YoY -1.8%), operating income of 3.55 billion yen (-12.9%), ordinary income of 3.67 billion yen (-10.5%), and net income of 2.41 billion yen (-2.5%). The company demonstrates a revenue down/profit down pattern with pronounced margin compression. Operating margin declined to 9.3% from prior year levels, reflecting structural headwinds in the CRO segment where a major client internalized operations, alongside deliberate strategic investments including staff compensation increases and platform development. Despite revenue decline remaining modest at -1.8%, operating profit dropped -12.9%, indicating negative operating leverage. Net income held relatively stable at -2.5% decline due to non-operating income partially offsetting operational weakness. The company maintains robust liquidity with cash and deposits of 16.69 billion yen representing 40% of total assets and a current ratio of 380.1%, though receivables DSO exceeding 60 days warrants monitoring.

Performance Drivers

Revenue decreased 1.8% YoY to 38.12 billion yen, driven by a sharp 15.9% decline in CRO segment sales to 5.1 billion yen, partially offset by 0.8% growth in Human Resource Services to 33.0 billion yen. The CRO segment contraction stemmed from a major client internalizing operations and the sale of unprofitable overseas operations, representing structural rather than cyclical factors. Human Resource Services benefited from higher dispatch unit prices and improved utilization rates of permanent dispatch staff, though growth remained subdued.

Operating income fell 12.9% to 3.55 billion yen as operating margin compressed to 9.3% from 10.5% in the prior year. Gross profit margin of 23.1% generated gross profit of 8.80 billion yen, against which SG&A expenses reached 5.25 billion yen. The margin deterioration reflects strategic investments including April 2025 dispatch staff compensation increases aimed at enhancing recruitment competitiveness, platform development costs for "doconico" and "Doco-1" services, and maintaining CRO processing personnel despite revenue decline to prepare for future orders. CRO segment operating profit plunged 40.5% to 732 million yen with operating margin declining to 14.4% from prior year levels.

Ordinary income decreased 10.5% to 3.67 billion yen, outperforming operating income due to non-operating income of 122 million yen. The 1.2 billion yen gap between operating income (3.55 billion yen) and ordinary income (3.67 billion yen) suggests immaterial non-operating contributions. Net income declined only 2.5% to 2.41 billion yen despite the operating profit decline, aided by extraordinary gains of 46 million yen exceeding extraordinary losses of 51 million yen, and a net non-recurring benefit, though the effective tax rate of 34.3% remained elevated.

Earnings quality concerns include receivables DSO exceeding 60 days flagged in XBRL analysis, indicating potential collection delays that could impact cash conversion. Non-recurring items were minimal, with extraordinary gains and losses largely offsetting. The disproportionate stability of net income relative to operating income decline suggests one-time benefits or tax adjustments partially cushioned operational weakness.

The company exhibits a revenue down/profit down pattern, with structural revenue headwinds in CRO and strategic margin investments in Human Resource Services driving operating leverage deterioration. Management guidance maintains full-year forecasts of 51.14 billion yen revenue (0% YoY) and 4.33 billion yen ordinary income (-15.0% YoY), indicating expected Q4 challenges with higher SG&A expenses typical of the period.

Segment Analysis

The Human Resource Services segment is the core business, contributing 330.1 billion yen in revenue (86.6% of total) and 3.36 billion yen in operating income. Revenue grew 0.8% YoY while operating income increased 4.8%, demonstrating margin expansion to 10.2% from prior year levels. This performance was driven by higher dispatch unit prices reflecting April 2025 compensation increases passed through to clients, and improved utilization rates of permanent dispatch staff. The segment absorbed increased personnel costs while controlling SG&A expense growth, indicating operational discipline. Strategic initiatives include strengthening sales capabilities, expanding proposals for senior and part-time workforce segments, and region-specific new graduate hiring for permanent dispatch to enhance recruitment capacity.

The CRO (Contract Research Organization) segment generated revenue of 5.1 billion yen (13.4% of total) and operating income of 732 million yen. Revenue declined sharply by 15.9% YoY while operating income plunged 40.5%, with operating margin compressing to 14.4%. The primary driver was a major client internalizing operations previously outsourced, alongside the sale of unprofitable overseas operations. Despite revenue contraction, the company maintained processing personnel levels in anticipation of future order intake, resulting in pronounced margin pressure. Subsidiary MedFiles is focusing resources on higher-margin business areas to improve profitability. Recovery depends on successful business development to offset lost volumes and improved operational efficiency.

The core Human Resource Services segment drove overall revenue stability and delivered positive operating leverage with margin expansion despite strategic cost investments. Conversely, CRO segment structural headwinds significantly pressured consolidated operating profit, contributing disproportionately to the 12.9% consolidated operating income decline. The 6.2 percentage point margin differential between CRO (14.4%) and Human Resource Services (10.2%) highlights CRO's higher profitability on a smaller base, amplifying the impact of its volume decline on consolidated results.

Key Metrics

Profitability: ROE 6.7% (calculated via DuPont decomposition: Net Profit Margin 5.9% × Asset Turnover 0.917× Financial Leverage 1.23×), operating margin 9.3% (declined from 10.5% prior year), gross profit margin 23.1%. ROE of 6.7% remains below the company's sustainable earnings power, indicating room for improvement through margin recovery and asset efficiency gains.

Efficiency: Total asset turnover 0.917× reflects relatively efficient asset utilization for a service business. Receivables DSO exceeds 60 days per XBRL quality alerts, indicating potential collection challenges that could constrain working capital efficiency. Operating working capital turnover of 180.94 billion yen indicates substantial positive working capital position supported by strong cash balances.

Financial Health: Equity ratio 81.0% (336.8 billion yen equity / 415.8 billion yen total assets), current ratio 380.1% (24.55 billion yen current assets / 6.46 billion yen current liabilities), quick ratio 380.0%. Debt-to-equity ratio 0.23× (7.9 billion yen total liabilities / 33.68 billion yen equity) reflects conservative capital structure. Cash and deposits of 16.69 billion yen provide substantial liquidity buffer representing 40% of total assets.

Capital Allocation: Balance sheet changes include inventory -86.1% to 9 million yen (immaterial for service business), treasury stock increased in absolute value by 726 million yen (-56.8% change in negative equity line item), and intangible assets -47.0% to 70 million yen. The treasury stock movement suggests either buyback activity or valuation adjustments, warranting clarification given management's stated policy of not conducting buybacks due to liquidity ratio considerations. The intangible asset decline likely reflects software amortization or platform development asset revaluation.

Cash Flow Analysis

Operating cash flow data is not disclosed in the provided XBRL data, preventing direct assessment of cash earnings quality through OCF/Net Income ratio analysis. This represents a material information gap for evaluating whether the 2.41 billion yen net income is converting to cash, particularly given the receivables DSO warning exceeding 60 days.

Investing cash flow and capital expenditure details are not disclosed. Given the company's stated strategic investments in platform development (doconico, Doco-1) and October 2025 headquarters relocation from Himeji to Kobe, capital deployment information would provide valuable context for evaluating growth investments versus maintenance spending.

Financing cash flow details are not disclosed. Dividends paid totaled interim 24.0 yen and year-end 38.5 yen per share with annual forecast of 37.5 yen, implying a calculated payout ratio of 55.5% against net income. Without financing CF data, verification of actual cash dividends paid versus accrued amounts is not possible.

Free cash flow cannot be calculated due to missing operating CF and capital expenditure data. With cash and deposits of 16.69 billion yen and strong current ratio of 380.1%, the company appears to maintain ample liquidity to fund dividends and investments. However, the receivables collection warning and lack of CF disclosure create uncertainty regarding sustainable cash generation capacity.

Cash generation assessment: Adequate liquidity but needs monitoring. The substantial cash balance provides a buffer, but operating CF disclosure is essential to confirm earnings quality and dividend coverage. The DSO warning signals potential working capital strain that could constrain cash conversion despite reported profitability.

Earnings Quality

Ordinary income of 3.67 billion yen versus net income of 2.41 billion yen reflects a standard tax burden with effective tax rate of 34.3%. The 122 million yen non-operating income and net extraordinary items (46 million yen gains less 51 million yen losses) represent 3.2% of revenue and 5.1% of ordinary income, indicating immaterial non-recurring contributions.

Non-recurring factors were minimal in Q3 cumulative results. Extraordinary items netted to a small negative 5 million yen, suggesting limited one-time distortions. However, the disproportionate stability of net income (-2.5%) versus operating income (-12.9%) decline suggests potential tax adjustments or prior period items partially cushioned the operational weakness.

Accruals and earnings quality: Operating CF data is unavailable, preventing direct accruals analysis. The receivables DSO exceeding 60 days warning signals a potential earnings quality concern, as revenue may be recognized but not yet converted to cash. Inventory decreased sharply by 86.1%, though immaterial in absolute terms at 9 million yen given service business nature. Treasury stock increased significantly (absolute value up 726 million yen), representing a capital transaction rather than earnings item but warranting monitoring for capital allocation implications.

Overall earnings quality assessment: Moderate concerns warrant monitoring. The core business model appears sound with recurring service revenues, but receivables collection timing creates uncertainty. The lack of operating CF disclosure prevents verification that reported earnings translate to cash, particularly critical given the dividend payout ratio of 55.5%. Full-year guidance forecasts 4.23 billion yen operating income (-16.5% YoY) and 2.41 billion yen net income, indicating management expects persistent margin pressure through Q4.

Guidance Update

Full-year FY2026 guidance remains unchanged at revenue 51.14 billion yen (0% YoY), operating income 4.23 billion yen (-16.5% YoY), ordinary income 4.33 billion yen (-15.0% YoY), and net income 2.41 billion yen. Annual dividend forecast is 37.5 yen per share.

Q3 cumulative progress versus full-year guidance: Revenue 74.6% (38.12 billion yen / 51.14 billion yen), operating income 84.0% (3.55 billion yen / 4.23 billion yen), ordinary income 84.8% (3.67 billion yen / 4.33 billion yen), net income 100.0% (2.41 billion yen / 2.41 billion yen). Against a standard 75% Q3 benchmark, revenue tracks 0.4 percentage points below while profits track significantly ahead.

The net income progress rate of 100% indicates full-year earnings have already been achieved through Q3, suggesting Q4 will face material headwinds or guidance incorporates conservatism. Management noted in presentation materials that Q4 typically incurs higher SG&A expenses, implying sequential profit decline. The 84% operating income progress implies 680 million yen Q4 operating income versus 3.55 billion yen Q3 cumulative, indicating expected sharp Q4 margin compression.

No guidance revisions were announced. Management maintains confidence in full-year targets despite Q3 tracking ahead, suggesting deliberate conservatism or anticipated Q4 pressures from seasonal SG&A expenses, platform development investments, and continued CRO segment challenges. The 100% net income achievement through Q3 indicates potential for full-year upside if Q4 headwinds prove less severe than expected, though operating income and ordinary income tracking at 84% suggests limited margin for error.

Shareholder Returns

Dividend policy: Interim dividend of 24.0 yen and year-end dividend of 38.5 yen per share were paid, with full-year forecast of 37.5 yen per share representing a calculated payout ratio of 55.5%. Management targets a baseline payout ratio of 40% while maintaining stability even during unexpected events, as stated in presentation materials. The current 55.5% ratio exceeds the 40% baseline, reflecting commitment to shareholder returns despite earnings pressure.

Dividend sustainability: With cash and deposits of 16.69 billion yen and equity ratio of 81.0%, the balance sheet provides substantial capacity to sustain dividends. However, operating cash flow is undisclosed, preventing verification of cash dividend coverage. The receivables DSO warning exceeding 60 days introduces uncertainty regarding cash generation quality. Given net income of 2.41 billion yen and estimated total dividend payments on approximately 19.6 million shares (based on equity structure), annual dividends would total roughly 735 million yen or 30.5% of net income, comfortably covered by reported earnings but requiring CF confirmation.

Share buyback: Management explicitly stated in presentation materials that buybacks are not typically conducted due to liquidity ratio considerations. The 726 million yen increase in treasury stock (absolute value) during the period appears inconsistent with this stated policy and may reflect prior period holdings, disposal restrictions, or technical accounting adjustments rather than new buyback activity. Clarification is warranted.

Total return: Based on annual dividend of 37.5 yen per share and no active buyback program, total shareholder return is limited to dividends representing 55.5% payout ratio. Management prioritizes long-term enterprise value growth through strategic investments (staff compensation increases, platform development) over near-term shareholder distributions, as articulated in presentation materials emphasizing long-term value maximization over short-term profits.

Catalysts

Near-term (within 12 months):

• Q4 FY2026 results and FY2027 guidance: Full-year net income has already reached guidance of 2.41 billion yen through Q3, creating potential for upside surprise if Q4 headwinds prove manageable, or confirming margin pressure if seasonal SG&A expenses materialize as management expects.
• Doco-1 platform adoption: The multiple dispatch company unified management system launched May 2025 is reportedly gaining orders smoothly per presentation materials. Accelerating client adoption could drive platform revenue growth and validate the strategic investment case.
• CRO segment stabilization: Business development efforts to offset lost major client volume and MedFiles' focus on higher-margin services should begin showing results in FY2027, providing visibility on segment profit recovery timeline.

Long-term (beyond 12 months):

• Platform business monetization: Doconico and Doco-1 platform investments aim to establish recurring revenue streams and industry infrastructure positioning. Achieving scale could materially enhance profit margins and create competitive moats in dispatch services coordination.
• Dispatch staff compensation strategy payoff: April 2025 wage increases positioning the company as highest-paying in the industry should improve talent attraction and retention, driving market share gains and utilization rate improvements as labor market tightness persists.
• Operating leverage recovery: As platform investments and restructuring costs moderate while revenue stabilizes, operating margins should expand from current 9.3% toward historical levels, supported by Human Resource Services segment scale benefits and CRO segment rationalization.

Industry Benchmark (Reference - Proprietary Data)

Industry Position (Reference - Proprietary Analysis)

The company operates in the IT and Telecom services sector based on benchmark classification. Comparative analysis against industry medians for FY2025 Q3 (n=92-99 companies) reveals positioning as follows:

Profitability: ROE 6.7% versus industry median 8.2% (IQR: 3.5%-13.3%), placing the company below median in shareholder return generation. Operating margin 9.3% compares to industry median 8.0% (IQR: 3.4%-17.4%), positioning slightly above median. Net profit margin 5.9% versus industry median 5.6% (IQR: 2.2%-12.0%) indicates near-median profitability. The company's ROE underperformance despite near-median net margin reflects lower asset turnover and financial leverage versus peers.

Efficiency: Asset turnover 0.917× exceeds industry median 0.68× (IQR: 0.52-0.95), indicating superior asset utilization efficiency. Receivables turnover DSO flagged at 60+ days aligns closely with industry median 60.53 days (IQR: 45.96-79.94), suggesting collection timing is industry-typical rather than company-specific weakness, though still warrants monitoring.

Financial Health: Equity ratio 81.0% substantially exceeds industry median 59.5% (IQR: 43.7%-72.8%), reflecting conservative balance sheet positioning. Current ratio 380.1% far exceeds industry median 2.13× (IQR: 1.56×-3.58×), indicating exceptional liquidity. The company maintains net cash position, contrasted with industry median net debt/EBITDA of -2.85× (IQR: -5.50 to -0.13), placing the company among the most conservatively capitalized peers.

Growth: Revenue growth -1.8% compares unfavorably to industry median +10.5% (IQR: -1.6% to +20.5%), positioning the company in the bottom quartile. This underperformance reflects CRO segment structural headwinds rather than market share losses in core Human Resource Services.

Rule of 40: Calculated as revenue growth -1.8% plus operating margin 9.3% equals 7.5%, substantially below industry median 20% (IQR: 2%-34%). This indicates the company is not meeting software/services sector growth-profitability balance standards, reflecting current margin compression and revenue headwinds.

Overall assessment: The company exhibits industry-leading financial strength (equity ratio, liquidity) and asset efficiency (turnover), but lags in growth and shareholder returns (ROE). Operational profitability (operating margin, net margin) is near-median, suggesting competitive positioning in core markets. The primary opportunity lies in restoring revenue growth and operating leverage to translate balance sheet strength into superior ROE performance.

(Industry: IT and Telecom Services, n=92-99 companies, Comparison period: FY2025 Q3, Source: Proprietary Analysis)

Risk Factors

CRO business structural headwinds: The CRO segment experienced 15.9% revenue decline and 40.5% operating profit decline in Q3 cumulative results, driven by a major client internalizing previously outsourced operations and sale of unprofitable overseas operations. Segment operating margin compressed to 14.4% as the company maintained processing personnel despite volume decline to prepare for future orders. Recovery depends on successful business development to replace lost volumes and MedFiles' shift to higher-margin services. If client internalization trends persist or new order intake disappoints, further CRO profit deterioration could pressure consolidated results despite the segment representing only 13.4% of revenue. Quantified impact: CRO operating profit declined 500 million yen YoY in Q3; full continuation would represent 11% reduction in consolidated operating income.

Receivables collection delays: XBRL analysis flags receivables DSO exceeding 60 days, creating cash conversion risk. While industry benchmark shows median DSO of 60.53 days suggesting this is sector-typical, extended collection periods constrain working capital efficiency and could strain liquidity if deterioration continues. With receivables of 6.32 billion yen representing 16.6% of Q3 cumulative revenue annualized, a 10-day DSO extension would tie up approximately 630 million yen additional working capital. Operating cash flow is undisclosed, preventing verification of cash collection quality. If DSO extends further or collection issues emerge, dividend sustainability and investment capacity could be constrained despite strong current cash position of 16.69 billion yen.

Strategic investment margin pressure: Management is deliberately compressing margins through April 2025 dispatch staff compensation increases (to become industry-leading wage provider), platform development investments (doconico, Doco-1), and maintenance of excess CRO capacity for future growth. Operating margin declined to 9.3% from 10.5% prior year, with full-year guidance implying further Q4 compression. If revenue growth does not materialize to leverage these investments, or competitive dynamics prevent recovering increased labor costs through pricing, margins could remain depressed beyond current expectations. The company's ROE of 6.7% already trails the industry median of 8.2%; persistent margin pressure without revenue acceleration would further widen this gap and pressure shareholder returns. Full-year operating income guidance of 4.23 billion yen implies Q4 operating income of only 680 million yen versus 3.55 billion yen Q3 cumulative, indicating management expects significant near-term margin challenges.

Key Takeaways from Earnings

Strategic transformation in progress with near-term margin trade-offs: The company is executing a deliberate strategy to invest in long-term competitive positioning through highest-in-industry dispatch staff compensation, platform infrastructure development, and capacity maintenance for future growth. This resulted in operating margin compression to 9.3% from prior year 10.5% and operating income decline of 12.9% despite revenue declining only 1.8%, demonstrating significant negative operating leverage. Full-year guidance implies Q4 operating income of just 680 million yen following 3.55 billion yen Q3 cumulative achievement, with net income guidance already 100% complete through Q3. Management explicitly prioritizes long-term enterprise value over near-term profitability as stated in presentation materials. The success of this strategy hinges on achieving talent acquisition and retention advantages that drive market share gains in Human Resource Services, and platform adoption creating new recurring revenue streams. Early indicators include Doco-1 launch in May 2025 reportedly gaining orders smoothly, and Human Resource Services segment demonstrating margin expansion to 10.2% while absorbing compensation increases. Investors should monitor wage strategy's impact on talent acquisition metrics, platform adoption rates, and timeline for operating leverage recovery as investments moderate.

Exceptional financial strength provides strategic flexibility but requires improved capital productivity: The company maintains cash and deposits of 16.69 billion yen (40% of assets), equity ratio of 81.0% versus industry median 59.5%, and current ratio of 380.1% versus industry median 2.13×, positioning among the most financially robust sector peers. Asset turnover of 0.917× exceeds industry median 0.68×, indicating efficient capital utilization. However, ROE of 6.7% trails industry median 8.2% despite near-median profitability margins (operating margin 9.3% versus 8.0% median, net margin 5.9% versus 5.6% median), reflecting underleveraged balance sheet and subdued growth. The financial fortress enables sustained dividends (55.5% payout ratio versus 40% target baseline) and strategic investments during margin pressure periods, but requires revenue growth acceleration to translate strength into superior shareholder returns. Management's stated policy against buybacks and conservative leverage suggests intent to preserve financial flexibility for organic investments and potential M&A rather than optimize capital structure. The path to ROE improvement requires either margin expansion as investments bear fruit, revenue growth acceleration, or increased financial leverage - with management apparently prioritizing the first two paths.

Revenue growth restoration critical to validating investment thesis: The company's -1.8% revenue decline compares unfavorably to industry median growth of +10.5%, positioning in the bottom quartile. Core Human Resource Services segment grew only 0.8% despite market labor shortages, while CRO segment contracted 15.9% due to structural client losses. Rule of 40 metric of 7.5% (revenue growth -1.8% plus operating margin 9.3%) significantly underperforms industry median 20%, indicating failure to meet services sector growth-profitability standards. Management guidance projects 0% revenue growth for full-year FY2026, suggesting persistent headwinds. Strategic initiatives targeting revenue include sales force expansion, senior/part-time workforce proposals, region-specific graduate hiring for permanent dispatch, and platform service launches. If these initiatives drive acceleration toward mid-to-high single-digit growth while margin investments moderate, the company could achieve Rule of 40 improvement and operating leverage recovery. Conversely, if revenue remains stagnant while investment spending continues, margin compression could persist and ROE remain below industry median. Q1 FY2027 results and guidance will provide critical validation of whether strategic investments are driving growth inflection or require strategy reassessment.

---

This report was automatically generated by AI integrating XBRL earnings data and PDF presentation materials as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.

---

AI Analysis (Earnings Presentation)

AI analysis of PDF earnings presentation

Summary

Presentation materials for WDB Holdings' FY2026/3 Q3 results. The company holds a 30% domestic share in science-related staffing. Net sales were 38.12 billion yen (YoY -1.8%) and ordinary profit was 3.67 billion yen (-10.5%), resulting in lower earnings. The Human Resources Services segment achieved higher sales and profits driven by higher dispatch unit prices and improved utilization of permanent-employee staffing. The CRO business posted lower sales and profits due to insourcing by key clients and the divestiture of unprofitable overseas operations. Full-year guidance is maintained at net sales of 51.14 billion yen and ordinary profit of 4.33 billion yen. The company plans an annual dividend of 62.5 yen (payout ratio 50.9%). It continues to invest in the platform business (doconico, Doco1) and is building the foundation for sustainable growth.

Key Highlights

Maintains an industry-leading position with approximately 30% share in the science-related staffing market. Will raise compensation for temporary staff in April 2025, advancing a strategy to become the staffing firm of choice among job seekers. Will launch the multi-agency staffing management system “Doco1” in May 2025, with orders progressing smoothly. Targets a payout ratio of 40% as a baseline, aiming to sustain stable dividends even under unforeseen circumstances. Will relocate headquarters from Himeji, Hyogo Prefecture to Kobe in October 2025 to strengthen the sales organization.

Business Outlook

Full-year guidance is maintained at net sales of 51.14 billion yen (YoY 0.0%) and ordinary profit of 4.33 billion yen (-15.0%). The Human Resources Services segment will pursue growth through strengthening the sales organization, enhancing proposals to senior and part-time segments, and region-specific hiring of new graduates for permanent-employee staffing. The CRO business will focus on sales activities and quality improvements to offset reviews of outsourcing scope and work-hours. Medfiles will concentrate management resources on higher-margin services to drive order growth. While SG&A expenses are expected to be heavier in Q4, execution toward achieving the full-year plan is progressing steadily.

Management Guidance

Management aims to maximize long-term shareholder returns through future-oriented corporate development rather than prioritizing short-term profits or shareholder returns. The company seeks to offer the highest compensation for dispatched staff in the industry to become the staffing firm chosen by more job seekers. It will continue investing in platform development and other areas to build a foundation for sustainable growth. A 40% payout ratio is the baseline, with a policy of maintaining stable dividends. Share buybacks will generally not be conducted, given alignment with the current ratio criterion.

Strategic Initiatives

Strengthen talent acquisition and improve job seeker satisfaction by increasing compensation for temporary staff. Enhance the sales organization to better match client needs and improve retention of existing staff. Expand adoption of the multi-agency staffing management platform “Doco1” and grow the platform business. Strengthen hiring capabilities through region-specific recruitment of new graduates for permanent-employee staffing. In the CRO business, conduct sales activities and quality improvements to offset reviews of outsourcing scope and work-hours.

Disclosed Risks

Order declines in the CRO business due to insourcing by key clients. Profit margin erosion in the CRO business as processing personnel are being maintained amid lower sales. Short-term margin pressure from raising compensation for dispatched staff. Potential short-term margin stagnation due to investments in platform development. Structural susceptibility of the Human Resources Services business to economic cycles.

---

AI Financial Analysis

Executive Summary

FY2026 Q3 earnings were mixed: revenue and operating profit declined, while profit attributable to owners was broadly flat due to a lower tax burden. Revenue for the nine months ended December 2025 was ¥38.12bn, down 1.8% year on year. Operating income declined 12.9% to ¥3.55bn. Ordinary income fell 10.5% to ¥3.67bn. Profit attributable to owners of parent was ¥2.26bn, up 0.1% year on year. The gross margin contracted by 32bp year on year to 23.1%. The SG&A-to-sales ratio rose by 86bp to 13.8%. Consequently, the operating margin compressed by 119bp to 9.3%, remaining within the generally sound 8-15% range but showing clear negative operating leverage. The Human Resources Services business remained the core business, contributing ¥33.62bn of segment profit, or 82.1% of aggregate segment profit, and delivered modest growth. In contrast, CRO profit fell sharply as both domestic and overseas revenue declined. Corporate costs increased ¥183m year on year to ¥541m, further amplifying the decline in consolidated operating income. The effective tax rate declined to 34.3% from approximately 39.3% a year earlier, cushioning the impact of weaker pretax profit on attributable earnings. Net profit margin was 5.9%, improving modestly by roughly 12bp based on attributable profit despite the operating-margin decline. The balance sheet remains highly liquid, with ¥16.69bn of cash and deposits and a 380.1% current ratio. Equity increased to ¥33.68bn, while total liabilities declined to ¥7.91bn. Full-year guidance implies a relatively strong fourth-quarter contribution, particularly for revenue, and the company has retained its FY2026 earnings targets. Nine-month progress against full-year guidance is 74.5% for revenue, 84.0% for operating income, 84.8% for ordinary income, and 93.7% for profit attributable to owners. The principal issue for the final quarter is whether Human Resources Services resilience can offset continued revenue and profit pressure in the CRO business.

Profitability Analysis

The reported annualized ROE is 8.9%, decomposed into a 5.9% net profit margin, 1.222x annualized asset turnover, and 1.23x financial leverage. The return profile is driven principally by operating efficiency and a conservative capital structure rather than balance-sheet leverage. Financial leverage of 1.23x is low, meaning there is limited leverage-related amplification of shareholder returns and limited solvency risk. The most material earnings change was operating-margin compression: the gross margin declined 32bp to 23.1%, while SG&A rose to 13.8% of sales from approximately 12.9%. This 86bp SG&A-rate increase, combined with lower revenue, drove the 119bp operating-margin decline to 9.3%. SG&A increased 4.8% to ¥5.25bn despite a 1.8% revenue decline, indicating unfavorable operating leverage at the consolidated level. Segment performance identifies CRO as the primary source of the decline: CRO revenue fell 15.9% to ¥5.11bn and segment profit fell 40.5% to ¥733m, reducing its margin to 14.4% from 20.3%. Human Resources Services improved segment profit by 4.8% to ¥3.36bn on 0.8% revenue growth, lifting its segment margin by 39bp to 10.2%. The lower effective tax rate supported attributable profit, but it does not offset the deterioration in operating profitability. Interest burden was 1.032, reflecting net non-operating income rather than a material financing cost burden. The tax burden of 0.616 is below the 0.70 reference level, reflecting a 34.3% effective tax rate; this was favorable versus the prior period but remains a significant deduction from pretax earnings.

Growth Assessment

Consolidated revenue declined 1.8% to ¥38.12bn, with segment trends diverging sharply. Human Resources Services revenue increased 0.8% to ¥33.02bn and accounted for 86.6% of external revenue, reinforcing its role as the principal earnings base. Within this segment, temporary staffing revenue rose 0.7% to ¥32.51bn and placement revenue increased 5.2% to ¥506m. CRO revenue declined 15.9% to ¥5.11bn. Domestic CRO revenue fell 9.6% to ¥3.83bn, while overseas CRO revenue declined 30.5% to ¥1.27bn. The overseas CRO contraction is the largest negative contributor to group revenue performance and increases the importance of stabilization in this activity. Aggregate segment profit declined 7.8% to ¥4.09bn, but the decline at consolidated operating-income level was larger because corporate costs increased 51.3%. Full-year guidance calls for revenue of ¥51.14bn, flat year on year, operating income of ¥4.23bn, down 16.5%, ordinary income of ¥4.33bn, down 15.0%, and attributable profit of ¥2.41bn. Revenue progress of 74.5% is broadly aligned with the 75% Q3 seasonal reference point. Operating-income and ordinary-income progress are each about 9-10 percentage points ahead of the 75% reference point, suggesting a comparatively modest implied fourth-quarter contribution. Attributable-profit progress of 93.7% is 18.7 percentage points above the reference point, largely indicating that the annual forecast embeds substantially lower Q4 attributable earnings than the nine-month pace. The outlook therefore depends on maintaining staffing profitability, limiting further CRO margin pressure, and controlling corporate expenses.

Financial Health

Financial health is strong. Current assets of ¥24.55bn exceeded current liabilities of ¥6.46bn by ¥18.09bn, producing working capital of ¥18.09bn. The current ratio was 380.1% and the quick ratio was 380.0%, indicating that short-term obligations are covered several times over by highly liquid assets. Cash and deposits totaled ¥16.69bn, equal to 2.58x current liabilities. Total liabilities represented only 19.0% of total assets, while total equity represented 81.0%. The debt-to-equity ratio was 0.23x, well below the 1.0x conservative-capital-structure reference point and far from the 2.0x warning threshold. Noncurrent liabilities were ¥1.45bn, modest relative to ¥17.03bn of noncurrent assets and ¥33.68bn of equity. Accounts payable were broadly stable at ¥2.31bn, while trade receivables fell 2.0% to ¥6.32bn, consistent with the slight revenue decline. Cash and deposits decreased by ¥3.88bn year on year, but the remaining cash position remains substantial. Property, plant and equipment increased by ¥2.99bn to ¥15.06bn and represented 36.2% of total assets, making the asset base more capital-intensive than the prior period. The balance sheet contains limited intangible assets of ¥79m, or 0.2% of total assets, and no reported goodwill, limiting acquisition-accounting and goodwill-impairment exposure. Provisions include ¥641m for bonuses, ¥576m for directors' retirement benefits, and a ¥385m net defined-benefit liability; these obligations are readily supportable within the company’s liquidity and equity base.

Notable B/S Changes

Cash and deposits: -¥3.88bn (-18.9%) to ¥16.69bn - liquidity remains strong, but cash deployment and conversion of investment into returns should be monitored. Property, plant and equipment: +¥2.99bn (+24.8%) to ¥15.06bn - fixed-asset intensity increased, making utilization of buildings and other operating assets more important for capital efficiency. Construction in progress: -¥3.74bn (-98.9%) to ¥0.43bn - suggests completion or transfer of major capital projects into operating fixed assets. Inventories: -¥56m (-86.1%) to ¥9m - inventory is immaterial and the reduction limits working-capital exposure. Treasury stock: +¥726m (+56.8% in absolute carrying amount) to -¥2.00bn - indicates increased capital allocation to treasury-share holdings and warrants monitoring alongside dividends. Intangible assets: -¥70m (-47.0%) to ¥79m - intangible-asset exposure is now negligible at 0.2% of total assets.

Cash Flow Quality

The company generated ¥2.26bn of profit attributable to owners in the nine-month period and ended the period with ¥16.69bn of cash and deposits. Cash balances declined by ¥3.88bn year on year while property, plant and equipment increased by ¥2.99bn and construction in progress decreased by ¥3.74bn, consistent with a material shift in the fixed-asset base. The large reduction in construction in progress suggests completion or reclassification of investment projects into operating fixed assets. Receivables decreased by ¥128m and inventories decreased by ¥56m, so the reported balance-sheet movements do not indicate a buildup of these working-capital items alongside the revenue decline. Inventory is immaterial at ¥9m. The ¥49m loss on disposal of fixed assets was largely offset by a ¥46m gain on transfer of business, leaving the net extraordinary effect immaterial to pretax earnings. Operating income of ¥3.55bn remained substantially above the net fixed-asset disposal loss, supporting the view that core earnings remain primarily operating in nature.

Dividend Sustainability

The company paid an interim dividend of ¥25.00 per share for FY2026. Full-year dividend guidance is ¥62.50 per share, implying a year-end dividend of ¥37.50 per share. Based on forecast EPS of ¥122.72, the implied FY2026 dividend payout ratio is 50.9%. This is below the 60% sustainability reference point and leaves room for earnings retention. The interim dividend represented approximately 22% of nine-month attributable earnings on the disclosed calculation basis. Retained earnings totaled ¥32.16bn, substantially exceeding annual dividends implied by the forecast. The company’s liquidity is also robust, with ¥16.69bn in cash and deposits and low leverage. Treasury stock increased by ¥726m year on year to ¥2.00bn; this indicates capital returned or reserved through share repurchases, although a total-return ratio cannot be determined from the disclosed information. Dividend sustainability is therefore supported by the balance sheet and the forecast payout ratio, while future dividend growth will depend on recovery in consolidated operating-profit momentum.

Risk Assessment

Business risks include CRO business deterioration is the highest operating risk: revenue declined 15.9% and segment profit fell 40.5%, with overseas CRO revenue down 30.5%., The Human Resources Services business accounts for 86.6% of external revenue, creating concentration in staffing-market demand, client hiring activity, and availability of qualified personnel., Labor-market conditions, wage inflation, and competition for technical and scientific talent can pressure staffing spreads and recruitment profitability., CRO operations face industry-specific risks from pharmaceutical and biotech R&D budgets, clinical-development timing, client project cancellations or delays, and cross-border execution in overseas operations., Corporate costs rose 51.3% year on year, and continued cost growth above revenue growth would constrain consolidated margin recovery..

Financial risks include The cash balance declined ¥3.88bn year on year while fixed assets increased, requiring monitoring of the cash-generation profile as the enlarged asset base is utilized., Property, plant and equipment represent 36.2% of total assets, increasing exposure to asset utilization and future disposal or impairment risk if demand weakens., Treasury stock increased by ¥726m to ¥2.00bn; continued repurchases would need to remain aligned with operating cash generation and investment requirements., The effective tax rate improved materially year on year; if it normalizes upward, attributable-profit growth could lag operating-profit recovery..

Key concerns include Highest priority: CRO margin fell from 20.3% to 14.4%, substantially faster than the group-level margin decline., High priority: consolidated operating margin fell 119bp because SG&A increased despite lower sales., Moderate priority: the full-year attributable-profit forecast is nearly achieved after nine months, implying limited forecast Q4 profit and sensitivity to final-quarter items., Moderate priority: the substantial reduction in construction in progress and increase in PPE should translate into productive asset utilization rather than lower capital efficiency..

Investment Implications

Key takeaways include The core Human Resources Services business remained resilient, with 0.8% revenue growth and 4.8% segment-profit growth., CRO weakness, especially in overseas operations, was the dominant drag on revenue and operating profit., Operating profitability weakened despite essentially flat attributable profit, as a lower tax rate offset lower pretax earnings., The company retains a conservative balance sheet, with 81.0% equity/assets, a 380.1% current ratio, and a 0.23x debt-to-equity ratio., FY2026 dividend guidance implies a 50.9% forecast payout ratio, which appears balanced against earnings and retained capital..

Metrics to watch include CRO domestic and overseas revenue growth, CRO segment margin versus the FY2026 Q3 level of 14.4%, Human Resources Services segment margin versus the FY2026 Q3 level of 10.2%, SG&A growth relative to consolidated revenue growth, Fourth-quarter delivery versus full-year operating-income guidance of ¥4.23bn, Cash balance and productivity of the expanded ¥15.06bn PPE base, Treasury-stock movement and the resulting total return ratio.

Regarding relative positioning, WDB Holdings combines a financially conservative balance sheet with an operating margin of 9.3%, which remains in a solid range for service businesses. Its return profile is supported by annualized asset turnover rather than leverage. Relative operating positioning is currently bifurcated: Human Resources Services is stable and profitable, whereas CRO profitability has weakened materially and is the principal determinant of near-term earnings normalization.